Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28994512 | 0.98 | LMNA (0.39) | LMNA | |
| SCHEMBL2151634 | 0.98 | LMNA (0.39) | LMNA | |
| SCHEMBL19468519 | 0.98 | LMNA (0.39) | LMNA | |
| SCHEMBL11171519 | 0.98 | LMNA (0.39) | LMNA | |
| SCHEMBL3842284 | 0.98 | LMNA (0.39) | LMNA | |
| SCHEMBL19468488 | 0.98 | LMNA (0.39) | LMNA | |
| SCHEMBL8984323 | 0.98 | LMNA (0.39) | LMNA | |
| SCHEMBL9000968 | 0.98 | LMNA (0.39) | LMNA | |
| SCHEMBL30229872 | 0.98 | LMNA (0.39) | LMNA | |
| SCHEMBL29787970 | 0.98 | LMNA (0.39) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118027894-A | Adhesive, negative electrode slurry and lithium ion battery | 深圳好电科技有限公司 | 2024-05-14 | — | — | CN | claimed |
| CN-118027894-A | Adhesive, negative electrode slurry and lithium ion battery | 深圳好电科技有限公司 | 2024-05-14 | — | — | CN | disclosed |
| US-20230374194-A1 | POLYISOCYANATE COMPOSITION, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | WANHUA CHEMICAL GROUP CO LTD (CN) | 2023-11-23 | — | — | US | disclosed |
| CN-111269128-B | Synthesis method of 1,1' - (hexa-2, 4-diyne-1, 6-diyl) bis (3-alkyl urea) compound | 苏州爱玛特生物科技有限公司 | 2022-08-30 | — | — | CN | disclosed |
| US-20210317324-A1 | MULTILAYER COATING FILM AND METHOD FOR PRODUCING THE SAME | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2021-10-14 | — | — | US | disclosed |
| CN-111269128-A | Synthesis method of 1, 1' - (hexa-2, 4-diyne-1, 6-diyl) bis (3-alkyl urea) compound | 苏州爱玛特生物科技有限公司 | 2020-06-12 | — | — | CN | disclosed |
| EP-2111443-A2 | BENEFIT AGENT DELIVERY COMPOSITIONS | The Procter and Gamble Company (US) | 2009-10-28 | — | — | EP | disclosed |
| US-7595403-B2 | Benzisothiazol-3-one-carboxylic acid amides as phospholipase inhibitors | ELI LILLY AND COMPANY (US) | 2009-09-29 | — | — | US | disclosed |
| US-7595403-B2 | Benzisothiazol-3-one-carboxylic acid amides as phospholipase inhibitors | ELI LILLY AND COMPANY (US) | 2009-09-29 | — | — | US | disclosed |
| EP-1610779-B1 | 3-OXO-1,3-DIHYDRO-INDAZOLE-2-CARBOXYLIC ACID AMIDE DERIVATIVES AS PHOSPHOLIPASE INHIBITORS | LILLY CO ELI (US) | 2009-09-09 | — | — | EP | disclosed |
| US-7217727-B2 | Phospholipase inhibitors | ELI LILLY AND COMPANY (US) | 2007-05-15 | — | — | US | disclosed |
| US-7217727-B2 | Phospholipase inhibitors | ELI LILLY AND COMPANY (US) | 2007-05-15 | — | — | US | disclosed |
| US-20060211755-A1 | 3-oxo-1, 3-dihydro-indazole-2-carboxylic acid amide derivatives as phospholipase inhibitors | ELI LILLY AND COMPANY PATENT DIVISION (US) | 2006-09-21 | — | — | US | disclosed |
| US-20060116409-A1 | Phospholipase inhibitors | ELILILLY AND COMPANY | 2006-06-01 | — | — | US | disclosed |
| EP-1615900-A1 | BENZISOTHIAZOL-3-ONE-CARBOXYLIC ACID AMIDES AS PHOSPHOLIPASE INHIBITORS | ELI LILLY AND COMPANY (US) | 2006-01-18 | — | — | EP | disclosed |
| EP-1613608-A1 | PHOSPHOLIPASE INHIBITORS | ELI LILLY AND COMPANY (US) | 2006-01-11 | — | — | EP | disclosed |
| EP-1610779-A1 | 3-OXO-1,3-DIHYDRO-INDAZOLE-2-CARBOXYLIC ACID AMIDE DERIVATIVES AS PHOSPHOLIPASE INHIBITORS | ELI LILLY AND COMPANY (US) | 2006-01-04 | — | — | EP | disclosed |
| WO-2004093872-A1 | 3-OXO-1, 3-DIHYDRO-INDAZOLE-2-CARBOXYLIC ACID AMIDE DERIVATIVES AS PHOSPHOLIPASE INHIBITORS | ELI LILLY AND COMPANY (US) | 2004-11-04 | — | — | WO | disclosed |
| WO-2004094394-A1 | BENZISOTHIAZOL-3-ONE-CARBOXYLIC ACID AMIDES AS PHOSPHOLIPASE INHIBITORS | ELI LILLY AND COMPANY (US) | 2004-11-04 | — | — | WO | disclosed |
| WO-2004094393-A1 | PHOSPHOLIPASE INHIBITORS | ELI LILLY AND COMPANY (US) | 2004-11-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060211755-A1 | 3-oxo-1, 3-dihydro-indazole-2-carboxylic acid amide derivatives as phospholipase inhibitors | C5AR2, C3AR1, C5AR1 | LMNA 924/4885BLM 1089/4885ALDH1A1 2776/4885 |
| US-20060116409-A1 | Phospholipase inhibitors | LIPG, PNLIP, LIPC | LMNA 884/4885BLM 1160/4885ALDH1A1 1347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.